SOTAX

SOTAX, founded in 1973, is a specialized provider of pharmaceutical testing solutions, focusing on automation for critical laboratory processes. The company leverages extensive expertise in dissolution, disintegration, tablet hardness, and sample preparation to serve the global pharmaceutical sector. Their commitment to innovation is evident in their development of advanced automated systems designed to streamline complex testing workflows. This foundational focus on precision and efficiency has positioned SOTAX as a key player in the manufacturing and test & measurement equipment industries.

Operating with a workforce of 500 - 1,000 employees across 16 global locations, SOTAX offers a comprehensive portfolio of products. This includes a range of sophisticated dissolution testers, physical testing equipment, and sample preparation systems engineered for diverse dosage forms like tablets, capsules, and injectable suspensions. These solutions are vital for pharmaceutical companies worldwide seeking to ensure product quality and regulatory compliance. For insights into the individuals driving these advancements, one can Meet SOTAX's team. The company's revenue stands at $151.7M, reflecting its significant market presence.

Beyond its hardware offerings, SOTAX provides essential services such as method development, validation, and compliance support, ensuring clients can effectively integrate and utilize their testing solutions. Their technology aims to enhance testing efficiency and uphold data integrity, crucial aspects in pharmaceutical research and development. The company's strategic approach and dedication to quality underscore its role in advancing pharmaceutical science and manufacturing standards globally.